$0.0230
At close: May 14, 9:30 AM EDT
Comments
Loading...
Willow Biosciences Analyst Ratings and Price Targets | OTC:CANSF | Benzinga
Willow Biosciences Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Willow Biosciences Corp from these most-recent analyst ratings.
Analyst Ratings for Willow Biosciences
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Willow Biosciences (CANSF) stock?
There is no price target for Willow Biosciences
What is the most recent analyst rating for Willow Biosciences (CANSF)?
There is no analyst for Willow Biosciences
When was the last upgrade for Willow Biosciences (CANSF)?
There is no last upgrade for Willow Biosciences
When was the last downgrade for Willow Biosciences (CANSF)?
There is no last downgrade for Willow Biosciences.
When is the next analyst rating going to be posted or updated for Willow Biosciences (CANSF)?
There is no next analyst rating for Willow Biosciences.
Is the Analyst Rating Willow Biosciences (CANSF) correct?
There is no next analyst rating for Willow Biosciences.
Browse analyst ratings and price targets on all stocks.
